These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 20701957)
21. Notch 1 signaling is active in ovarian cancer. Rose SL; Kunnimalaiyaan M; Drenzek J; Seiler N Gynecol Oncol; 2010 Apr; 117(1):130-3. PubMed ID: 20060575 [TBL] [Abstract][Full Text] [Related]
22. Activation of the PI3K/AKT pathway mediates FSH-stimulated VEGF expression in ovarian serous cystadenocarcinoma. Huang Y; Hua K; Zhou X; Jin H; Chen X; Lu X; Yu Y; Zha X; Feng Y Cell Res; 2008 Jul; 18(7):780-91. PubMed ID: 18574502 [TBL] [Abstract][Full Text] [Related]
23. Expression of glypican 3 in ovarian and extragonadal germ cell tumors. Zynger DL; Everton MJ; Dimov ND; Chou PM; Yang XJ Am J Clin Pathol; 2008 Aug; 130(2):224-30. PubMed ID: 18628091 [TBL] [Abstract][Full Text] [Related]
24. Gene silencing of glypican-3 in clear cell carcinoma of the ovary renders it more sensitive to the apoptotic agent paclitaxel in vitro and in vivo. Umezu T; Shibata K; Shimaoka M; Kajiyama H; Yamamoto E; Ino K; Nawa A; Senga T; Kikkawa F Cancer Sci; 2010 Jan; 101(1):143-8. PubMed ID: 19860840 [TBL] [Abstract][Full Text] [Related]
25. Aberration of the PI3K/AKT/mTOR signaling in epithelial ovarian cancer and its implication in cisplatin-based chemotherapy. Zhang HY; Zhang PN; Sun H Eur J Obstet Gynecol Reprod Biol; 2009 Sep; 146(1):81-6. PubMed ID: 19540648 [TBL] [Abstract][Full Text] [Related]
26. Protein chip discovery of secreted proteins regulated by the phosphatidylinositol 3-kinase pathway in ovarian cancer cell lines. Moscova M; Marsh DJ; Baxter RC Cancer Res; 2006 Feb; 66(3):1376-83. PubMed ID: 16452192 [TBL] [Abstract][Full Text] [Related]
27. Targeting CD24 for treatment of ovarian cancer by short hairpin RNA. Su D; Deng H; Zhao X; Zhang X; Chen L; Chen X; Li Z; Bai Y; Wang Y; Zhong Q; Yi T; Qian Z; Wei Y Cytotherapy; 2009; 11(5):642-52. PubMed ID: 19593703 [TBL] [Abstract][Full Text] [Related]
28. The Simpson-Golabi-Behmel syndrome causative glypican-3, binds to and inhibits the dipeptidyl peptidase activity of CD26. Davoodi J; Kelly J; Gendron NH; MacKenzie AE Proteomics; 2007 Jun; 7(13):2300-10. PubMed ID: 17549790 [TBL] [Abstract][Full Text] [Related]
29. [shRNA-mediated insulin-like growth factor I receptor gene silencing inhibits cell proliferation, induces cell apoptosis, and suppresses tumor growth in non-small cell lung cancer: in vitro and in vivo experiments]. Dong AQ; Kong MJ; Ma ZY; Qian JF; Fan JQ; Xu XH Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(21):1506-9. PubMed ID: 17785094 [TBL] [Abstract][Full Text] [Related]
30. HSulf-1 inhibits angiogenesis and tumorigenesis in vivo. Narita K; Staub J; Chien J; Meyer K; Bauer M; Friedl A; Ramakrishnan S; Shridhar V Cancer Res; 2006 Jun; 66(12):6025-32. PubMed ID: 16778174 [TBL] [Abstract][Full Text] [Related]
31. Cross-talk between MAP kinase pathways is involved in IGF-independent, IGFBP-6-induced Rh30 rhabdomyosarcoma cell migration. Fu P; Liang GJ; Khot SS; Phan R; Bach LA J Cell Physiol; 2010 Sep; 224(3):636-43. PubMed ID: 20432455 [TBL] [Abstract][Full Text] [Related]
32. Preclinical Efficacy for AKT Targeting in Clear Cell Carcinoma of the Ovary. Sasano T; Mabuchi S; Kuroda H; Kawano M; Matsumoto Y; Takahashi R; Hisamatsu T; Sawada K; Hashimoto K; Isobe A; Testa JR; Kimura T Mol Cancer Res; 2015 Apr; 13(4):795-806. PubMed ID: 25519148 [TBL] [Abstract][Full Text] [Related]
33. Oncogenic activation of glypican-3 by c-Myc in human hepatocellular carcinoma. Li L; Jin R; Zhang X; Lv F; Liu L; Liu D; Liu K; Li N; Chen D Hepatology; 2012 Oct; 56(4):1380-90. PubMed ID: 22706665 [TBL] [Abstract][Full Text] [Related]
35. Overexpression of GPC3 inhibits hepatocellular carcinoma cell proliferation and invasion through induction of apoptosis. Pan Z; Chen C; Long H; Lei C; Tang G; Li L; Feng J; Chen F Mol Med Rep; 2013 Mar; 7(3):969-74. PubMed ID: 23338845 [TBL] [Abstract][Full Text] [Related]
36. Enhanced expression of Annexin A4 in clear cell carcinoma of the ovary and its association with chemoresistance to carboplatin. Kim A; Enomoto T; Serada S; Ueda Y; Takahashi T; Ripley B; Miyatake T; Fujita M; Lee CM; Morimoto K; Fujimoto M; Kimura T; Naka T Int J Cancer; 2009 Nov; 125(10):2316-22. PubMed ID: 19598262 [TBL] [Abstract][Full Text] [Related]
37. Antitumor effects of interleukin-6 (IL-6)/interleukin-6 receptor (IL-6R) signaling pathway inhibition in clear cell carcinoma of the ovary. Yanaihara N; Hirata Y; Yamaguchi N; Noguchi Y; Saito M; Nagata C; Takakura S; Yamada K; Okamoto A Mol Carcinog; 2016 May; 55(5):832-41. PubMed ID: 25856562 [TBL] [Abstract][Full Text] [Related]
38. Soluble glypican 3 inhibits the growth of hepatocellular carcinoma in vitro and in vivo. Zittermann SI; Capurro MI; Shi W; Filmus J Int J Cancer; 2010 Mar; 126(6):1291-301. PubMed ID: 19816934 [TBL] [Abstract][Full Text] [Related]
39. "Piling up" clear cells in müllerian-type mucinous and mixed cell-type borderline tumor do not represent concomitant clear cell neoplasms. Ohishi Y; Kurihara S; Aman M; Takeuchi T; Imamura H; Kaku T; Kobayashi H; Wake N; Oda Y Hum Pathol; 2012 Oct; 43(10):1618-26. PubMed ID: 22436624 [TBL] [Abstract][Full Text] [Related]
40. Glypican-3 is expressed in rhabdomyosarcomas but not adult spindle cell and pleomorphic sarcomas. Thway K; Selfe J; Missiaglia E; Fisher C; Shipley J J Clin Pathol; 2011 Jul; 64(7):587-91. PubMed ID: 21493758 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]